ALZN - רווח תפעולי EBITDA alzamend.com

Alzamend Neuro, Inc. (ALZN) is implementing LiPRO technology for the safe treatment of Alzheimer's, while the GURU.Markets service features a linear chart of absolute operating profit, where the 0.00 metric indicates the status of the cash flow. Patent protection ensures long-term value growth, and strict adherence to the cold chain during drug transportation guarantees their efficacy throughout clinical trials.

This indicator measures the volume of cash flow from core operations before taxes, demonstrating the business's ability to generate liquidity excluding depreciation and amortization. An analysis based on the EBITDA_Co valuation allows for the tracking of capital inflows, which is critically important for Alzamend Neuro, Inc. (ALZN) when financing clinical trials for lithium-based drugs and maintaining competitiveness against anti-amyloid antibodies.